At the time of writing, Scholar Rock Holding Corp [SRRK] stock is trading at $46.05, up 2.93%. An important factor to consider is whether the stock is rising or falling in short-term value. The SRRK shares have gain 5.26% over the last week, with a monthly amount glided 7.27%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Scholar Rock Holding Corp [NASDAQ: SRRK] stock has seen the most recent analyst activity on January 09, 2026, when Citigroup initiated its Buy rating and assigned the stock a price target of $55. Previously, Wolfe Research started tracking the stock with Outperform rating on November 18, 2025, and set its price target to $42. On October 09, 2025, BofA Securities initiated with a Buy rating and assigned a price target of $53 on the stock. Barclays started tracking the stock assigning a Overweight rating and suggested a price target of $45 on September 17, 2025. Leerink Partners initiated its recommendation with a Outperform and recommended $51 as its price target on September 15, 2025.
For the past year, the stock price of Scholar Rock Holding Corp fluctuated between $22.71 and $48.28. Currently, Wall Street analysts expect the stock to reach $53.2 within the next 12 months. Scholar Rock Holding Corp [NASDAQ: SRRK] shares were valued at $46.05 at the most recent close of the market. An investor can expect a potential return of 15.53% based on the average SRRK price forecast.
Analyzing the SRRK fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.86, Equity is -1.22 and Total Capital is -1.04. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.45.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Scholar Rock Holding Corp [NASDAQ:SRRK] has a current ratio of 6.30. On the other hand, the Quick Ratio is 6.30, and the Cash Ratio is 4.63.
Transactions by insiders
Recent insider trading involved Qatanani Mo, CHIEF SCIENTIFIC OFFICER, that happened on Jan 16 ’26 when 8406.0 shares were sold. CHRO, Parlavecchio Caryn completed a deal on Jan 16 ’26 to sell 6600.0 shares. Meanwhile, CHIEF MEDICAL OFFICER Marantz Jing L. sold 5798.0 shares on Jan 16 ’26.
